Aligos Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing therapeutics to address unmet medical needs in viral and liver diseases. It uses its oligonucleotide and small molecule platforms to develop... Read more
MarketWatch
SeekingAlpha
SeekingAlpha
SeekingAlpha
Access detailed stock analysis from LSEG including analyst price target estimates.